We hypothesized that the overexpression of C1GALT1, identified as a negative indicator for patients’ prognosis in most cancer types, may alter tumor radiosensitivity in LUAD, thereby having critical consequences in cancer progression. Here, C1GALT1 is linked to neoplasm.